Health

Competition in Health Insurance Markets – Healthcare Economist

• Health

Competition in Health Insurance Markets – Healthcare Economist

Ak June 18, 2026

That’s the title of one Economic Perspectives Journal Article by Martin Gaynor and Amanda Stark (2026). The...

Read More Read more about Competition in Health Insurance Markets – Healthcare Economist

The Economic Case for Structured Exercise in GLP-1 Therapy – Healthcare Economist

• Health

The Economic Case for Structured Exercise in GLP-1 Therapy – Healthcare Economist

Ak June 15, 2026

That’s the title of one recent white paper Written by me and...

Read More Read more about The Economic Case for Structured Exercise in GLP-1 Therapy – Healthcare Economist

75 Years of Competition in Health Care Policy – Healthcare Economist

• Health

75 Years of Competition in Health Care Policy – Healthcare Economist

Ak June 12, 2026

When health economics emerged as a distinct discipline in the late 1960s,...

Read More Read more about 75 Years of Competition in Health Care Policy – Healthcare Economist

Why don’t health plans voluntarily cover GLP-1s for obesity? – Healthcare Economist

• Health

Why don’t health plans voluntarily cover GLP-1s for obesity? – Healthcare Economist

Ak June 9, 2026

ICER found GLP-1 drugs to be cost-effective for the treatment of obesity....

Read More Read more about Why don’t health plans voluntarily cover GLP-1s for obesity? – Healthcare Economist

Healthcare Economist Weekly Reader

• Health

Healthcare Economist Weekly Reader

Ak June 6, 2026

FDA recognized first in silico drug development tool. Why has GLP-1 become more affordable? CMS GLP-1 Balancing...

Read More Read more about Healthcare Economist Weekly Reader

Prevalence, adherence, and health care resource utilization in schizophrenia – Healthcare Economist

• Health

Prevalence, adherence, and health care resource utilization in schizophrenia – Healthcare Economist

Ak June 3, 2026

How can we characterize the epidemiology and health care resource utilization of...

Read More Read more about Prevalence, adherence, and health care resource utilization in schizophrenia – Healthcare Economist

Was German regulation able to halt the decline of brick-and-mortar pharmacies? – Healthcare Economist

• Health

Was German regulation able to halt the decline of brick-and-mortar pharmacies? – Healthcare Economist

Ak May 31, 2026

As online pharmacies have grown in prominence, the German government aims to pass laws to increase the...

Read More Read more about Was German regulation able to halt the decline of brick-and-mortar pharmacies? – Healthcare Economist

Are you fluent in AI?

• Health

Are you fluent in AI?

Ak May 28, 2026

Professor Rick Deacon (Ringling College of Art and Design) and Professor Joseph Feller (University College Cork) developed...

Read More Read more about Are you fluent in AI?

How long do Europeans have to wait for new pharmaceuticals after EMA approval? – Healthcare Economist

• Health

How long do Europeans have to wait for new pharmaceuticals after EMA approval? – Healthcare Economist

Ak May 25, 2026

The answer is provided by EFPIA’s annual WAIT indicator (press releases, reports)....

Read More Read more about How long do Europeans have to wait for new pharmaceuticals after EMA approval? – Healthcare Economist

Links

• Health

Links

Ak May 22, 2026

Ebola outbreak in Congo. AI mathematician. Why is long-term care policy failing? ISPOR: 1st, 2nd and 3rd...

Read More Read more about Links